Guido Valesini
Guido Valesini
Professore di Reumatologia, la Sapienza, Universitā di Roma
Verified email at uniroma1.it
Title
Cited by
Cited by
Year
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
JS Smolen, R Landewé, FC Breedveld, M Buch, G Burmester, ...
Annals of the rheumatic diseases 73 (3), 492-509, 2014
6666*2014
Treatment of pulmonary arterial hypertension
M Humbert, O Sitbon, G Simonneau
New England Journal of Medicine 351 (14), 1425-1436, 2004
20692004
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community
C Vitali, S Bombardieri, HM Moutsopoulos, G Balestrieri, W Bencivelli, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1993
17871993
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S Van Assen, N Agmon-Levin, O Elkayam, R Cervera, MF Doran, ...
Annals of the rheumatic diseases 70 (3), 414-422, 2011
6792011
Anti-inflammatory and immunosuppressive drugs and reproduction
M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ...
Arthritis research & therapy 8 (3), 1-19, 2006
6012006
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ...
Annals of the rheumatic diseases 71 (1), 4-12, 2012
5512012
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR …
JL Nam, KL Winthrop, RF van Vollenhoven, K Pavelka, G Valesini, ...
Annals of the rheumatic diseases 69 (6), 976-986, 2010
5122010
Sjöc; gren's Syndrome: Autoimmune Epithelitis
HM Moutsopoulos
Clinical immunology and immunopathology 72 (2), 162-165, 1994
4901994
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical …
C Alessandri, M Bombardieri, N Papa, M Cinquini, L Magrini, A Tincani, ...
Annals of the rheumatic diseases 63 (10), 1218-1221, 2004
2712004
Inflammation as “common soil” of the multifactorial diseases
R Scrivo, M Vasile, I Bartosiewicz, G Valesini
Autoimmunity reviews 10 (7), 369-374, 2011
2582011
Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo
C Ferri, V Pittoni, A Piccoli, O Laurenti, MR Cassone, C Bellini, G Properzi, ...
The Journal of Clinical Endocrinology & Metabolism 80 (3), 829-835, 1995
2521995
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid‐like structures in Sjögren's syndrome
F Barone, M Bombardieri, A Manzo, MC Blades, PR Morgan, ...
Arthritis & Rheumatism 52 (6), 1773-1784, 2005
2432005
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs
M Østensen, M Lockshin, A Doria, G Valesini, P Meroni, C Gordon, ...
Rheumatology 47 (suppl_3), iii28-iii31, 2008
2112008
Anti–β2‐glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts
M Sorice, A Longo, A Capozzi, T Garofalo, R Misasi, C Alessandri, F Conti, ...
Arthritis & Rheumatism 56 (8), 2687-2697, 2007
2112007
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice
M Blank, D Faden, A Tincani, J Kopolovic, I Goldberg, B Gilburd, F Allegri, ...
Journal of autoimmunity 7 (4), 441-455, 1994
2101994
Citrullination and autoimmunity
G Valesini, MC Gerardi, C Iannuccelli, VA Pacucci, M Pendolino, ...
Autoimmunity reviews 14 (6), 490-497, 2015
2022015
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?
G Balestrieri, A Tincani, L Spatola, F Allegri, E Prati, R Cattaneo, ...
Lupus 4 (2), 122-130, 1995
2021995
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived …
C Vitali, G Palombi, C Baldini, M Benucci, S Bombardieri, M Covelli, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
2012007
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ...
Annals of the rheumatic diseases 74 (5), 859-866, 2015
1972015
Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis …
M Bombardieri, F Barone, F Humby, S Kelly, M McGurk, P Morgan, ...
The Journal of Immunology 179 (7), 4929-4938, 2007
1972007
The system can't perform the operation now. Try again later.
Articles 1–20